G

Gentian Diagnostics
GENT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
NOK851.31M
EV
NOK766.59M
Shares Outstanding
15.56M
Beta
0.39
Industry
Medical - Devices

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
1
P/E 2025E
34.25x
P/Revenue 2025E
4.29x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Gentian Diagnostics ASA

gainify

G

Gentian Diagnostics ASA

GENT

Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circula...

Sector

Healthcare

Industry

Medical - Devices

CEO

Heinonen, Matti

Employees

63

IPO Date

2016-12-14

Headquarters

BjOernAsveien 5, Moss, Østfold, 1596, Norway

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.